220 related articles for article (PubMed ID: 34238306)
1. Pharmacist attitudes and provision of harm reduction services in North Carolina: an exploratory study.
Parry RA; Zule WA; Hurt CB; Evon DM; Rhea SK; Carpenter DM
Harm Reduct J; 2021 Jul; 18(1):70. PubMed ID: 34238306
[TBL] [Abstract][Full Text] [Related]
2. Pharmacists' nonprescription syringe dispensing perceptions and behaviors: A three-state descriptive analysis.
Hagemeier NE; Dowling-McClay K; Baladezaei M; Curtis SJ; Spence M
Drug Alcohol Depend; 2021 Apr; 221():108597. PubMed ID: 33631542
[TBL] [Abstract][Full Text] [Related]
3. Predicting pharmacy syringe sales to people who inject drugs: Policy, practice and perceptions.
Meyerson BE; Davis A; Agley JD; Shannon DJ; Lawrence CA; Ryder PT; Ritchie K; Gassman R
Int J Drug Policy; 2018 Jun; 56():46-53. PubMed ID: 29558701
[TBL] [Abstract][Full Text] [Related]
4. A qualitative study on pharmacy policies toward over-the-counter syringe sales in a rural epicenter of US drug-related epidemics.
Fadanelli M; Cooper HLF; Freeman PR; Ballard AM; Ibragimov U; Young AM
Harm Reduct J; 2022 Jan; 19(1):1. PubMed ID: 34996466
[TBL] [Abstract][Full Text] [Related]
5. Rural and small metro area naloxone-dispensing pharmacists' attitudes, experiences, and support for a frontline public health pharmacy role to increase naloxone uptake in New York State, 2019.
Tofighi B; Lekas HM; Williams SZ; Martino D; Blau C; Lewis CF
J Subst Abuse Treat; 2021 Oct; 129():108372. PubMed ID: 34080543
[TBL] [Abstract][Full Text] [Related]
6. I could take the judgment if you could just provide the service: non-prescription syringe purchase experience at Arizona pharmacies, 2018.
Meyerson BE; Lawrence CA; Cope SD; Levin S; Thomas C; Eldridge LA; Coles HB; Vadiei N; Kennedy A
Harm Reduct J; 2019 Sep; 16(1):57. PubMed ID: 31533730
[TBL] [Abstract][Full Text] [Related]
7. Pharmacists' attitudes and practices about selling syringes to people who inject drugs in Tajikistan: Results of a syringe purchase audit and a survey.
Ibragimov U; Haardörfer R; Cooper HLF; Dunkle KL; Zule WA; Wong FY
Int J Drug Policy; 2019 Sep; 71():62-72. PubMed ID: 31226505
[TBL] [Abstract][Full Text] [Related]
8. Nonprescription syringe sales: Resistant pharmacists' attitudes and practices.
Chiarello E
Drug Alcohol Depend; 2016 Sep; 166():45-50. PubMed ID: 27423213
[TBL] [Abstract][Full Text] [Related]
9. "I go out of my way to give them an extra smile now:" A study of pharmacists who participated in Respond to Prevent, a community pharmacy intervention to accelerate provision of harm reduction materials.
Irwin AN; Gray M; Ventricelli D; Boggis JS; Bratberg J; Floyd AS; Silcox J; Hartung DM; Green TC
Res Social Adm Pharm; 2024 May; 20(5):512-519. PubMed ID: 38395644
[TBL] [Abstract][Full Text] [Related]
10. Impact of the change in Connecticut syringe prescription laws on pharmacy sales and pharmacy managers' practices.
Wright-De Agüero L; Weinstein B; Jones TS; Miles J
J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S102-10. PubMed ID: 9663632
[TBL] [Abstract][Full Text] [Related]
11. Self-reported participation in voluntary nonprescription syringe sales in California's Central Valley.
Pollini RA
J Am Pharm Assoc (2003); 2017; 57(6):677-685. PubMed ID: 28807658
[TBL] [Abstract][Full Text] [Related]
12. Pharmacists' role in harm reduction: a survey assessment of Kentucky community pharmacists' willingness to participate in syringe/needle exchange.
Goodin A; Fallin-Bennett A; Green T; Freeman PR
Harm Reduct J; 2018 Jan; 15(1):4. PubMed ID: 29370808
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Bexar County community pharmacist attitudes toward harm reduction.
Shedd M; Bozhkova A; Kalich BA; Wilkening GL
Ment Health Clin; 2019 Nov; 9(6):383-391. PubMed ID: 31857934
[TBL] [Abstract][Full Text] [Related]
14. Stigmatization of people who inject drugs (PWID) by pharmacists in Tajikistan: sociocultural context and implications for a pharmacy-based prevention approach.
Ibragimov U; Cooper HL; Haardörfer R; Dunkle KL; Zule WA; Wong FY
Harm Reduct J; 2017 Sep; 14(1):64. PubMed ID: 28915888
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of providing interventions for injection drug users in pharmacy settings: a case study among San Francisco pharmacists.
Rose VJ; Lutnick A; Kral AH
J Psychoactive Drugs; 2014; 46(3):226-32. PubMed ID: 25052881
[TBL] [Abstract][Full Text] [Related]
16. Attitudes, beliefs, knowledge, and practices for over-the-counter syringe sales in community pharmacies: A systematic review.
Gionfriddo MR; Owens KM; Leist SE; Schrum LT; Covvey JR
J Am Pharm Assoc (2003); 2023; 63(5):1472-1489.e3. PubMed ID: 37429389
[TBL] [Abstract][Full Text] [Related]
17. Attitudes and availability: A comparison of naloxone dispensing across chain and independent pharmacies in rural and urban areas in Alabama.
Sisson ML; McMahan KB; Chichester KR; Galbraith JW; Cropsey KL
Int J Drug Policy; 2019 Dec; 74():229-235. PubMed ID: 31698165
[TBL] [Abstract][Full Text] [Related]
18. Non-prescription pharmacy syringes sales to people who inject drugs (PWID) in Khartoum, Sudan: policy, practice, and perceptions.
Siddig A; Elhassan M; Ali MM; Farah A; Elkhalifa M; Elawad EH; Hassan I; Haboura O; Digna MF; Mohamedalhadi Alamin Alkhalifamohamed H
Am J Drug Alcohol Abuse; 2022 May; 48(3):328-333. PubMed ID: 35130448
[No Abstract] [Full Text] [Related]
19. Pharmacists' attitudes about pharmacy sale of needles/syringes and needle exchange programs in a city without needle/syringe prescription laws.
Gleghorn AA; Gee G; Vlahov D
J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S89-93. PubMed ID: 9663630
[TBL] [Abstract][Full Text] [Related]
20. Pharmacist and pharmacy staff experiences with non-prescription (NP) sale of syringes and attitudes toward providing HIV prevention services for injection drug users (IDUs) in Providence, RI.
Zaller N; Jeronimo A; Bratberg J; Case P; Rich JD
J Urban Health; 2010 Dec; 87(6):942-53. PubMed ID: 21116724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
